1-(2-pivaloylaminopyridin-3-yl)ethanone | 161987-58-2

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 1-(2-pivaloylaminopyridin-3-yl)ethanone
• 英文别名: 3-acetyl-2-(pivaloylamino)pyridine；N-(3-acetylpyridin-2-yl)-2,2-dimethylpropanamide；N-(3-acetylpyridin-2-yl)pivalamide
• CAS: 161987-58-2
• 化学式: C₁₂H₁₆N₂O₂
• 分子量: 220.271
• InChiKey: VSQIBTHKSDKEPR-UHFFFAOYSA-N

物化性质

• 熔点：
  67-68 °C
• 沸点：
  415.7±30.0 °C(Predicted)
• 密度：
  1.119±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  59.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-(2-pivaloylaminopyridin-3-yl)ethanone 在 sodium tetrahydroborate 、 盐酸羟胺 、 potassium tert-butylate 、 三乙胺 作用下， 以 甲醇 、 乙醇 为溶剂， 生成 [5-(2-氨基吡啶-3-基)异恶唑-3-基]甲醇
  参考文献：
  名称：

  一种氘代的异恶唑类化合物的制备方法和用途

  摘要：

  本发明公开了如式(I)所示的氘代异恶唑类化合物或其前药的制备方法和用途。本发明所述的氘代异恶唑类化合物及其前药可作为真菌GPI锚定蛋白合成酶抑制剂应用于抗真菌感染药物方面。

  公开号：

  CN110776505A
• 作为产物：
  描述：

  2-tert-butyl-4-methyl-4H-pyrido[2,3-d][1,3]oxazin-4-yl pivalate 在 盐酸 、 水 、 sodium hydroxide 作用下， 以 甲苯 、 水 为溶剂， 反应 0.5h， 生成 1-(2-pivaloylaminopyridin-3-yl)ethanone
  参考文献：
  名称：

  HETEROCYCLIC RING AND PHOSPHONOXYMETHYL GROUP SUBSTITUTED PYRIDINE DERIVATIVES AND ANTIFUNGAL AGENT CONTAINING SAME

  摘要：

  本发明提供了具有优异抗真菌作用的化合物，同时在水溶性和安全性等方面也表现优异。这些化合物由式（I）表示： 本发明还涉及包括该化合物的药物组合物，以该化合物作为活性成分的抗真菌剂，以及通过给予该化合物来预防或治疗真菌病的方法。

  公开号：

  US20090233883A1

文献信息

• HETEROCYCLIC RING AND PHOSPHONOXYMETHYL GROUP SUBSTITUTED PYRIDINE DERIVATIVES AND ANTIFUNGAL AGENT CONTAINING SAME
  申请人：MATSUKURA Masayuki

  公开号：US20090233883A1

  公开（公告）日：2009-09-17

  The present invention provides compounds that have excellent antifungal action, and are also excellent in terms of properties, such as solubility in water and safety. The compounds are represented by formula (I): The present invention is also directed to a pharmaceutical composition comprising the compound, an antifungal agent comprising the compound as an active ingredient, and a method for preventing or treating a fungal disease by administering the compound.

  本发明提供了具有优异抗真菌作用的化合物，同时在水溶性和安全性等方面也表现优异。这些化合物由式（I）表示： 本发明还涉及包括该化合物的药物组合物，以该化合物作为活性成分的抗真菌剂，以及通过给予该化合物来预防或治疗真菌病的方法。
• Organic compounds
  申请人：BRUCE Ian

  公开号：US20090239847A1

  公开（公告）日：2009-09-24

  The present invention concerns a compound of formula (I) or a salt, suitably a pharmaceutically acceptable salt, or solvate thereof, wherein the groups R 1 , R 2 , Ar′, A and Y are defined in the description, to compositions and use of the compounds in the treatment of inflammatory and allergic conditions.

  本发明涉及一种化合物，其化学式为(I)或其盐，适宜为药用可接受的盐，或其溶剂化合物，其中基团R1、R2、Ar′、A和Y在描述中有定义，以及该化合物在治疗炎症和过敏症状中的应用。
• [EN] CONDENSED RING PYRIDINE COMPOUNDS AS SUBTYPE-SELECTIVE MODULATORS OF SPHINGOSINE-1-PHOSPHATE-2 (S1P2) RECEPTORS<br/>[FR] COMPOSÉS PYRIDINES À NOYAUX CONDENSÉS COMME MODULATEURS SÉLECTIFS D'UN SOUS-TYPE DES RÉCEPTEURS DE LA SPHINGOSINE-1-PHOSPHATE-2 (S1P2)
  申请人：ALLERGAN INC

  公开号：WO2011041287A1

  公开（公告）日：2011-04-07

  The invention provides compounds represented by the formula I, each of which compounds may have sphingosine-1-phosphate receptor agonist and or antagonist biological activity, wherein these compounds selected from the group consisting of wherein A, B, C, D, X, Y, Z and R3 are defined in the specification. Said compounds are useful for treating a disease or condition of a mammal selected from the group consisting of ocular diseases; systemic vascular barrier related diseases; allergies and other inflammatory diseases; cardiac diseases or conditions; fibrosis; pain and wounds.

  该发明提供了由公式I表示的化合物，其中每个化合物可能具有鞘氨醇-1-磷酸受体激动剂和/或拮抗剂生物活性，这些化合物选自由A、B、C、D、X、Y、Z和R3定义的组成的组中。所述化合物适用于治疗从眼部疾病；全身血管屏障相关疾病；过敏和其他炎症性疾病；心脏疾病或症状；纤维化；疼痛和伤口中选择的哺乳动物的疾病或症状。
• METHOD FOR MANUFACTURING HETEROCYCLE SUBSTITUTED PYRIDINE DERIVATIVES
  申请人：Niijima Jun

  公开号：US20110263845A1

  公开（公告）日：2011-10-27

  It is an object of the present invention to provide an efficient method for manufacturing heterocycle-substituted pyridine derivatives. The present invention provides a method for manufacturing a compound represented by the following formula (I): the method including reacting a compound represented by the following formula (III): and a compound represented by the following formula (II): in a solvent and in the presence of a palladium catalyst and a base, wherein R 1 represents a hydrogen atom, etc.; R 2 represents a hydrogen atom, a C 1-6 alkyl group, an amino group that may be protected with a protective group, etc.; one of X and Y represents a nitrogen atom and the other represents a nitrogen atom or an oxygen atom; Q represents a leaving group; the ring A represents a 5- or 6-member heteroaryl ring or a benzene ring, which may have one or two halogen atoms or C 1-6 alkyl groups; Z represents a single bond, a methylene group, an ethylene group, an oxygen atom, etc.; R represents a hydrogen atom or a C 1-6 alkyl group, etc.; R 3 represents a hydrogen atom or a halogen atom, etc.; and R 4 represents a hydrogen atom or a halogen atom; provided that when Z represents a single bond, or when R 3 represents a hydrogen atom, then R 1 , R 2 , and R 4 cannot all be a hydrogen atom at the same time.

  本发明的目的是提供一种制造杂环取代吡啶衍生物的高效方法。本发明提供了一种制造以下式（I）化合物的方法：在溶剂和钯催化剂和碱存在下，将以下式（III）化合物和以下式（II）化合物反应，其中R1代表氢原子等；R2代表氢原子，C1-6烷基，可能被保护基保护的氨基等；X和Y中的一个代表氮原子，另一个代表氮原子或氧原子；Q代表离去基团；环A代表5-或6-成员杂芳基环或苯环，可以有一或两个卤素原子或C1-6烷基；Z代表单键，亚甲基基，乙烯基，氧原子等；R代表氢原子或C1-6烷基等；R3代表氢原子或卤素原子等；R4代表氢原子或卤素原子；但当Z代表单键或当R3代表氢原子时，R1、R2和R4不能同时为氢原子。
• Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
  申请人：Eisai R&D Management Co., Ltd

  公开号：US08188119B2

  公开（公告）日：2012-05-29

  The present invention provides an antifungal agent which has excellent antifungal action, and which is also excellent in terms of its properties, and in particular its solubility in water and safety. The present invention discloses a compound represented by the following formula (I) or a salt thereof. wherein R1, R2, R3, R4, A, X, Y, and Z are defined in the specification.

  本发明提供了一种具有优异的抗真菌作用，且在其性质方面，特别是在水溶性和安全性方面也具有优异性的抗真菌剂。本发明公开了由下式（I）表示的化合物或其盐，其中R1、R2、R3、R4、A、X、Y和Z在说明书中有定义。